Lung Cancer Clinical Trial
Tempus NSCLC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With NSCLC Using NGS Assays
Summary
Non-interventional study that will be collecting clinical and molecular health information from patients with NSCLC who will receive longitudinal plasma biomarker profiling in addition to their standard of care therapy and disease surveillance.
Eligibility Criteria
Inclusion Criteria:
A known or suspected lung cancer
Undergoing or has undergone a transbronchial needle aspiration (TBNA) or lung biopsy of a lung nodule or lung mass or thoracic lymph node biopsy for the purpose of diagnosis or staging of lung cancer
Patients who don't undergo a biopsy and instead move directly to a surgical resection as dictated by the treating physician will be allowed to enter the study at the relevant time point
18 years old or older
Willing and able to provide informed consent
Willing to have additional blood samples collected during routine surveillance visits
Lung cancer diagnosis post-initial biopsy or resection
Exclusion Criteria:
Suspected sarcoidosis, lymphoma, or metastatic cancer from other sites (i.e., those without a known or suspected lung primary diagnosis)
Not willing to have additional blood samples collected
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 4 Locations for this study
Fountain Valley California, 92708, United States More Info
Principal Investigator
Canton Ohio, 44710, United States More Info
Principal Investigator
Cincinnati Ohio, 45220, United States More Info
Principal Investigator
Appleton Wisconsin, 54911, United States More Info
Principal Investigator
How clear is this clinincal trial information?

Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.